When to use
Cervical/intracranial arterial and venous CTA is the method of choice in emergency for stroke with suspected large-vessel occlusion, subarachnoid hemorrhage (ruptured aneurysm workup), cerebral venous thrombosis and cervical arterial dissection.
What to evaluate
- Carotid and vertebral patency (stenoses, occlusions, dissections).
- Circle of Willis: ACA, MCA, PCA and anatomical variants.
- Aneurysms: location, size, morphology (saccular, fusiform), rupture signs.
- Venous system: dural sinuses and deep cerebral veins — thrombosis signs (filling defects).
- In stroke: identify proximal occlusion (M1, ICA, ACA-A1, basilar) for thrombectomy eligibility.
Interactive template
Fill the blanks0/2
Técnica:
Exame realizado pela técnica multislice após a injeção do meio de contraste endovenoso.
Análise:
- Porção cranial das veias jugulares internas: calibre, trajeto e contrastação preservados.
- Seios sagital superior, reto, transversos e sigmoides: calibre, trajeto e contrastação preservados.
- Veia de Galeno e veias cerebrais internas: calibre, trajeto e contrastação preservados.
- Circulação patológica: ausente.
- Trombose venosa recente: ausente.
- Variações anatômicas: assimetria do calibre entre as veias jugulares internas e os seios sigmoides e transversos, menores à .
Comparação: Estudos anteriores não disponíveis.
Conclusão:
Angiotomografia venosa cerebral dentro dos parâmetros da normalidade.
How to use
- Replace each [...] with the exam's measurement or descriptor.
- Adapt the conclusion to your service protocol before signing.
- Use the template as a starting point — not a replacement for physician review.
- In Laudos.AI, dictate findings in natural speech and the AI structures text in this format for review.
Frequently asked
- Ischemic stroke — thrombectomy window?
- Basic window: up to 6 h from onset. Extended (DAWN/DEFUSE-3) up to 24 h in selected cases with clinical-radiologic mismatch, adequate ASPECTS and proximal occlusion.
- Incidental aneurysm — when to treat?
- Multidisciplinary decision. Consider: size (≥ 7 mm generally), location (posterior > anterior circulation), irregular morphology, symptoms, prior SAH and patient risk factors (PHASES score).
References
- Powers WJ et al., Stroke 2019.
- Greving JP et al., Lancet Neurol 2014 (PHASES).